Literature DB >> 15386410

Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.

Marie Stiborová1, Eva Frei, Petr Hodek, Manfred Wiessler, Heinz H Schmeiser.   

Abstract

Aristolochic acid (AA), a naturally occurring nephrotoxin and carcinogen, has been associated with the development of urothelial cancer in humans. Understanding which human enzymes are involved in AA activation and/or detoxication is important in the assessment of an individual's susceptibility to this plant carcinogen. Using the (32)P postlabeling assay, we examined the ability of microsomal samples from 8 human livers and from 1 human kidney to activate AAI, the major component of the plant extract AA, to metabolites forming adducts in DNA. Microsomes of both organs generated DNA adduct patterns reproducing those found in renal tissues from humans exposed to AA. 7-(deoxyadenosin-N(6)-yl)aristolactam I, 7-(deoxyguanosin-N(2)-yl)aristolactam I and 7-(deoxyadenosin-N(6)-yl)aristolactam II were identified as AA-DNA adducts formed from AAI by all human hepatic and renal microsomes. To define the role of human microsomal enzymes in the activation of AAI, we investigated the modulation of AAI-DNA adduct formation by cofactors and selective inhibitors of microsomal reductases, cytochrome P450 (CYP) enzymes, NADPH:CYP reductase and NADH:cytochrome b(5) reductase. We also determined whether the activities of CYP and NADPH:CYP reductase in different human hepatic microsomal samples correlated with the levels of AAI-DNA adducts formed by the same microsomal samples. On the basis of these studies, we attribute most of the activation of AAI in human hepatic microsomes to CYP1A2. In contrast to human hepatic microsomes, in human renal microsomes NADPH:CYP reductase is more effective in AAI activation. In addition, prostaglandin H synthase is another enzyme activating AAI in renal microsomes. The results demonstrate for the first time the potential of microsomal enzymes in human liver and kidney to activate AAI by nitroreduction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15386410     DOI: 10.1002/ijc.20564

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 2.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

Review 3.  Biological reactive intermediates (BRIs) formed from botanical dietary supplements.

Authors:  Birgit M Dietz; Judy L Bolton
Journal:  Chem Biol Interact       Date:  2010-10-21       Impact factor: 5.192

4.  Botanical dietary supplements gone bad.

Authors:  Birgit Dietz; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2007-03-16       Impact factor: 3.739

5.  Aristolochic acid I metabolism in the isolated perfused rat kidney.

Authors:  Horacio A Priestap; M Cecilia Torres; Robert A Rieger; Kathleen G Dickman; Tomoko Freshwater; David R Taft; Manuel A Barbieri; Charles R Iden
Journal:  Chem Res Toxicol       Date:  2011-12-14       Impact factor: 3.739

6.  A retrospective review of patients with urothelial cancer in 3,370 recipients after renal transplantation: a single-center experience.

Authors:  Aiying Zhang; Donghao Shang; Jian Zhang; Lei Zhang; Rui Shi; Fengqi Fu; Ye Tian
Journal:  World J Urol       Date:  2014-09-20       Impact factor: 4.226

7.  Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2.

Authors:  Marie Stiborová; Katerina Levová; Frantisek Bárta; Zhanquan Shi; Eva Frei; Heinz H Schmeiser; Daniel W Nebert; David H Phillips; Volker M Arlt
Journal:  Toxicol Sci       Date:  2011-11-15       Impact factor: 4.849

8.  Profiling of mRNA and long non-coding RNA of urothelial cancer in recipients after renal transplantation.

Authors:  Donghao Shang; Tie Zheng; Jian Zhang; Ye Tian; Yuting Liu
Journal:  Tumour Biol       Date:  2016-07-22

Review 9.  p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.

Authors:  Neda Slade; Ute M Moll; Branko Brdar; Arijana Zorić; Bojan Jelaković
Journal:  Mutat Res       Date:  2009-02-04       Impact factor: 2.433

10.  beta-Naphthoflavone protects mice from aristolochic acid-I-induced acute kidney injury in a CYP1A dependent mechanism.

Authors:  Ying Xiao; Xiang Xue; Yuan-feng Wu; Guo-zheng Xin; Yong Qian; Tian-pei Xie; Li-kun Gong; Jin Ren
Journal:  Acta Pharmacol Sin       Date:  2009-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.